CVR 32840787Private limited company (ApS)Fremstilling af farmaceutiske præparater (212000)GreveFounded 9 Apr 2010
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about HERTART ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
0
CVR, 2012
Gross profit
3.2M
DKK, annual report 2025
-23.3% on 2024
Result
+2.7M
DKK, annual report 2025
Equity
11.3M
DKK, annual report 2025
Vitrolife AB100% of capital and votes, since 1 Apr 2013
Operating company
Dandex estimate: revenue or gross profit in the 2025 reportPer Svenssonsince 9 May 2018
100% of capital and votessince 1 Apr 2013
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report a calibrated decision model reading the auditor's text, not registered by the company. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
9 May 2018 to 13 Nov 2026.
9 Apr 2010 to 13 Nov 2026.
2012, annual: 0 employees, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 |
|---|---|---|---|---|---|
| Employees | No count | No count | No count | 3 | 0 |
| FTE | 1 | 3 | 3 | 3 | 1 |
| Series | Quarterly | Quarterly | Quarterly | Annual | Annual |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Annual 2011 to 2012; quarterly Q2 2010 to Q4 2010.
Latest 2012, published 24 Jun 2014. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 2,285 | 4,293 | 1,876 | 4,191 | 3,213 |
| Operating profit | +2,285 | +4,293 | +1,876 | +4,191 | +3,213 |
| Result for the year | +1,775 | +3,356 | +1,596 | +3,485 | +2,675 |
| Equity | 8,037 | 3,593 | 5,189 | 8,674 | 11,350 |
| Total assets | 8,439 | 4,924 | 6,995 | 11,464 | 14,891 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 0 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | 127.4% | 87.9% | -56.3% | 123.4% | -23.3% |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 | 0note 2 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 3 Mar 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 31 Mar 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 19 Jan 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 24 Apr 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 31 May 2022
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For HERTART ApS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 13 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 13 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
11 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Bestyrelse:
Fratrådte:
Lars Peter Westrin, (formand), den 31.05.2022.
Tiltrådte:
Bo Lars Risberg, (formand), den 31.05.2022.
Bestyrelse:
Fratrådte:
Göran Olof Fredrik Mellbin, (formand), den 21.02.2020, Lars Peter Westrin, den 21.02.2020.
Tiltrådte:
Anna Jennie Marie Meyer, den 21.02.2020, Lars Peter Westrin, (formand), den 21.02.2020.
Bestyrelse:
Fratrådte:
Anna Mårtensson, den 09.05.2018, Jan Tony Winslöf, den 09.05.2018.
Tiltrådte:
Lars Peter Westrin, den 09.05.2018, Per Svensson, den 09.05.2018.
Direktion:
Bestyrelse:
Fratrådte:
.
Direktion:
Fratrådte:
Petra Sophia Apell, den 19.08.2016.
Tiltrådte:
Anna Mårtensson, den 19.08.2016.
Bestyrelse:
Fratrådte:
Daniel Johan Poté, den 04.04.2016.
Tiltrådte:
Petra Sophia Apell, den 04.04.2016.
Direktion:
Vedtægter ændret:
31.12.2011.
Bestyrelse:
Fratrådt som formand, men forbliver i bestyrelsen: Jan Tony Winslöf, den 31.12.2011.
Udtrådt af bestyrelsen:
Henrik Carlheim Dørge, den 31.12.2011, Bjarne Bo Jensen, den 31.12.2011.
Indtrådt i bestyrelsen:
Göran Olof Fredrik Mellbin (formand), den 31.12.2011, Daniel Johan Poté, den 31.12.2011.
Direktion:
Udtrådt af direktionen:
Bjarne Bo Jensen, den 31.12.2011.
Indtrådt i direktionen:
Jan Tony Winslöf (adm. dir), den 31.12.2011.
Vedtægter ændret:
02.06.2010.
Kapitalforhøjelse:
kr. 41.667,00 indbetalt kontant, kurs 4.800,00.
Kapitalen udgør herefter kr. 166.667,00.
Bestyrelse:
Indtrådt i bestyrelsen:
Jan Tony Winslöf (formand), den 02.06.2010.
Stiftelsesdato:
09.04.2010.
Seneste vedtægtsdato:
09.04.2010.
Kapital:
kr. 125.000,00.
Indbetalingsmåde:
i værdier kr. 125.000,00 til kurs 100,00.
Stiftere:
CVR-NR. 31422337 MEDBROKER INVEST ApS, Hovedgaden 20, 4621 Gadstrup, den 09.04.2010, CVR-NR. 32837670 BJARNE BO INVEST ApS, Vibygårdsvej 14, Gl.Viby, 4130 Viby Sjælland, den 09.04.2010.
Bestyrelse:
Henrik Carlheim Dørge, den 09.04.2010, Salgschef Bjarne Bo Jensen, den 09.04.2010.
Direktion:
Salgschef Bjarne Bo Jensen, den 09.04.2010.
Selskabet tegnes af to be¬sty¬rel¬ses¬med¬lemmer eller af selskabets admi¬ni¬strerende direktør og be¬sty¬rel¬ses¬for¬mand¬en i forening.
Revision:
CVR-NR. 14119299 PKF MUNKEBO JENSEN VINDELEV, STATSAUTORISERET REVISIONSAKTIESELSKAB, Hovedvejen 56, 2600 Glostrup, den 09.04.2010.
Første regnskabsår:
09.04.2010 - 31.12.2010.
Regnskabsår:
01.01 - 31.12.
1 registered in CVR.
P-number 1015978410Korskildelund 6, 2670 Greve
No other current company drawn.
No other current company drawn.